Hims & Hers Health announced the expansion of its Board of Directors from eight to nine members with the appointment of Kåre Schultz, 63, as an independent director, effective July 16, 2024. Schultz will serve until the company's 2025 annual meeting of stockholders or until his successor is elected.The Board has confirmed that Schultz meets the independence requirements under the New York Stock Exchange listing standards and the Securities Exchange Act. He will receive standard director compensation as outlined in the company's April 2024 proxy statement. Committee appointments are pending.

Hims & Hers Health announced the expansion of its Board of Directors from eight to nine members with the appointment of Kåre Schultz, 63, as an independent director, effective July 16, 2024. Schultz will serve until the company's 2025 annual meeting of stockholders or until his successor is elected.The Board has confirmed that Schultz meets the independence requirements under the New York Stock Exchange listing standards and the Securities Exchange Act. He will receive standard director compensation as outlined in the company's April 2024 proxy statement. Committee appointments are pending.